THE LATEST FROM US

News archive

Poor quality of Warfarin Therapy

17.11.2015 – Pekka Raatikainen presented a poster of a study conducted by EPID Research “Poor Quality of Warfarin Therapy is Associated With Elevated Risk Of Myocardial Infarction in Patients With Atrial Fibrillation. Results From the FinWAF Registry With 54568 Patients” in the ...

Children’s medication in the Nordic countries

12.11.2015 – Disa Långström presented the results of her Master’s Thesis supervised by EPID Research as poster “Children’s medication in the Nordic countries – Survey on national administrative register data” in the ISPOR 18th Annual European Congress, 7-11 No...

Treatment of type 2 diabetic patients

23.10.2015 – Our study, A retrospective nationwide cohort study to investigate the treatment of type 2 diabetic patients in Finland – DAHLIA, is now registered under the ENCePP Seal. The purpose of this study is to describe type 2 diabetes mellitus patients in Finland, especially their...

The risk of severe hypoglycaemia and use of certain antidiabetic drugs

18.9.2015 – A study on the risk of severe hypoglycaemia and use of certain antidiabetic drugs was presented in the 51st European Association for the Study of Diabetes Annual Meeting in Stockholm, Sweden (September 14-18, 2015). Oral presentation titled “The risk of severe hypoglycaemia e...

Research Director Dr. Pasi Korhonen’s presentation

28.8.2015 – Our Research Director Dr. Pasi Korhonen gave an oral presentation titled “Preliminary Results of Bladder Cancer Risk in Relation To Exposure To Pioglitazone Among Patients With T2DM in the Pan European Multi-Database Bladder Cancer Risk Characterisation Study” in the 3...

Multi-Database Bladder Cancer Risk Characterisation Study

8.6.2015 – Results of the Pan European Multi-Database Bladder Cancer Risk Characterisation Study were presented at American Diabetes Association’s 75th Scientific Session – for further information, please see press release – Poster...

DAHLIA study accepted in the ENCePP Register of Studies

13.4.2015 – A retrospective nationwide cohort study to investigate the treatment of type 2 diabetic patients in Finland – DAHLIA. Study accepted in the ENCePP Register of Studies. More detailed information about the study available here.  ...

Parkinson’s disease medication doesn’t increase risk of cancer

1.4.2015 – The risk of developing prostate cancer in entacapone and levodopa/DDCI users compared to levodopa/DDCI users without entacapone – A nation-wide retrospective register-based study – Pharmacoepidemiological study report published in ENCePP Register of Studies. As a resp...
Are you interested in learning more about how our RWE solutions can help you in your drug development and surveillance? Our team of experts is eager to discuss your specific needs. To learn more, please contact us at office@epidresearch.com.